"The athlete tested positive for EPO following a no-notice test conducted by the IAAF in Kenya."
Jemima Sumgong (pictured), the first Kenyan woman to win an Olympic gold in the marathon when she triumphed in Rio last year, has failed an out-of-competition dope test, athletics officials said Friday.
The 32-year-old, who is also the reigning London Marathon champion, tested positive for the banned blood booster EPO in a test by the International Association of Athletics Federations (IAAF) in her native Kenya.
"The IAAF can confirm that an anti-doping rule violation case concerning the athlete Jemima Jelagat Sumgong (Kenya) has commenced this week," the IAAF said.
"The athlete tested positive for EPO following a no-notice test conducted by the IAAF in Kenya," the sport's ruling body added.
"This was part of an enhanced IAAF out-of-competition testing programme dedicated to elite marathon runners which is supported by the Abbott World Marathon Majors group. The IAAF will make no further statement about this case until its conclusion."
Sumgong, who also tested positive for a banned substance in 2012, starred at the London Marathon last year, defying the odds to win despite suffering a bruising fall.
Steeled by her success in London, she then became the first Kenyan woman to win Olympic marathon gold, defeating Ethiopia's world champion Mare Dibaba in Rio to confirm her status as the world's top marathon runner of 2016.
Before news of her positive drugs test emerged, Sumgong had vowed to defend her London title on April 23.
London Marathon organisers said they were "extremely disappointed" at Sumgong's failed test.
"She is currently suspended from competition pending the B test and the outcome of the investigation. Sumgong will therefore not run in London on 23 April to defend the title she won last year," announced the race's chief executive Nick Bitel.
He added: "The London Marathon has always been at the forefront of the fight against doping. The race has a zero tolerance policy towards doping and athletes who are banned for a doping offence are banned for life from the event."
At the Rio Olympics, Sumgong defied temperatures of 28 degrees Celsius (82F) to claim an historic gold medal in a race that finished at the city's famed Sambodromo.
"I was never worried that I'd lose," said Sumgong, who added that victory made up for a disappointing showing at the 2008 Beijing Olympics. "At the 40 kilometre mark I knew the gold was mine."
Earlier this year, Sumgong was one of a number of top Kenyan athletes who welcomed a new initiative to eradicate doping, which has tarnished their image, agreeing to be monitored by doctors appointed by the IAAF and Athletics Kenya.
"It will be easy for us now to communicate with these doctors before we take any medicine when the need arises," said Sumgong.
The move came after an investigation by German television channel ARD and Britain's Sunday Times newspaper last July alleging that doping was rife at the elite training centre in Iten.
Sumgong's former training partner, the 2014 Chicago and Boston Marathon champion Rita Jeptoo, is serving a four-year ban after also testing positive for EPO.
Kenyan athletics boss chief Jackson Tuwei has warned that any athlete who failed to comply would not be selected to represent the country in international competitions.
"Forty-nine athletes have been found to have violated the WADA (World Anti-Doping Agency) code in the past five years but were cautioned according to the laws of the land and WADA code," said Tuwei.
News of Sumgong's test was welcomed by other athletes. US distance runner Emma Coburn, a bronze medallist in the 3,000m steeplechase at last year's Olympics, applauded the IAAF's out-of-competition testing.
"Out of competition testing is so important!! Well done, IAAF. I hope to see more productive results from no-notice out of competition tests," Coburn tweeted.
In 2012 Sumgong tested positive for steroid Prednisolone following the Boston marathon. She only served half of a two year ban after a successful appeal blamed the failed control on treatment for a hip injury.